NSAIDs Explained: How Ibuprofen, Naproxen, and Aspirin Work – and the Risks Most People Underestimate

NSAIDs – nonsteroidal anti-inflammatory drugs – are among the most widely used medications in the world. Ibuprofen (Advil, Motrin) and naproxen (Aleve) are sold over-the-counter in every pharmacy. Aspirin sits in most medicine cabinets. Prescription NSAIDs like celecoxib, diclofenac, and indomethacin are prescribed millions of times per year.

Because they’re so accessible, NSAIDs are often treated as inherently safe. They’re not. They are effective, well-understood medications – but with a side effect profile that warrants genuine understanding, particularly for anyone using them regularly, at high doses, or in the presence of certain medical conditions.

What NSAIDs Are and How They Work

NSAIDs work by inhibiting cyclooxygenase (COX) enzymes – specifically COX-1 and COX-2. These enzymes convert arachidonic acid (a fatty acid released from cell membranes during injury or inflammation) into prostaglandins and thromboxanes.

Prostaglandins have multiple roles:

• Mediating pain sensitization (making nerve endings more sensitive to stimuli)
• Causing fever (through hypothalamic effects)
• Producing inflammation (vasodilation, increased vascular permeability)
• Protecting the gastric lining (stimulating mucus production and bicarbonate secretion)
• Supporting kidney function (maintaining blood flow to kidneys under stress)
• Supporting platelet aggregation (thromboxane A2)
• Maintaining uterine tone during pregnancy

By inhibiting COX enzymes and reducing prostaglandin production, NSAIDs achieve their therapeutic effects:

• Analgesia (pain relief): Reducing peripheral sensitization and central pain signaling
• Anti-inflammatory effect: Reducing vasodilation, edema, and immune cell recruitment
• Antipyretic effect: Lowering fever through hypothalamic effects
• Antiplatelet effect (aspirin specifically): Inhibiting thromboxane A2-mediated platelet aggregation

The same mechanism that produces these benefits also produces most side effects – because prostaglandins the drugs suppress also serve protective functions.

COX-1 vs COX-2: The Key Distinction

COX-1 is constitutively expressed (always present) in most tissues. It produces prostaglandins responsible for:

• Gastric mucosal protection (stimulating mucus and bicarbonate)
• Platelet aggregation (via thromboxane A2)
• Kidney function maintenance

COX-2 is inducible – it’s upregulated at sites of inflammation, injury, and by certain hormones. Its prostaglandins mediate:

• Inflammation, pain, and fever
• Some kidney function
• Endothelial prostacyclin production (which inhibits platelet aggregation and causes vasodilation)

Traditional non-selective NSAIDs (ibuprofen, naproxen, diclofenac, indomethacin, ketorolac) inhibit both COX-1 and COX-2. The anti-inflammatory benefit comes primarily from COX-2 inhibition; the GI harm comes primarily from COX-1 inhibition.

Selective COX-2 inhibitors (coxibs) – celecoxib (Celebrex) primarily – were developed to capture COX-2’s anti-inflammatory effects while sparing COX-1’s protective effects. This successfully reduced GI side effects but created a new problem: COX-2 in the vascular endothelium produces prostacyclin (antiplatelet, vasodilatory), while platelet COX-1 produces thromboxane A2 (pro-clotting). Selectively inhibiting COX-2 without inhibiting platelet COX-1 tips the balance toward thrombosis – explaining the cardiovascular risks of coxibs (the Vioxx/rofecoxib episode is the most prominent example).

Aspirin: Different From Other NSAIDs

Aspirin (acetylsalicylic acid) inhibits COX irreversibly – permanently acetylating the enzyme. Other NSAIDs inhibit COX reversibly (the enzyme function returns after the drug clears).

This irreversible platelet inhibition by aspirin is the basis of its antiplatelet use. Platelets have no nucleus and can’t make new COX enzymes – once aspirin inactivates their COX, they can’t aggregate via thromboxane A2 for their entire lifespan (7-10 days). This is why aspirin is used for:

• Secondary prevention of cardiovascular events (after MI or stroke) – recommended by AHA/ACC
• Primary prevention in very high-risk patients – now more selectively recommended given bleeding risk

Aspirin for primary prevention update: The 2022 ACC/AHA guidelines significantly narrowed the primary prevention recommendation. Aspirin is no longer recommended for primary prevention in adults 60+ (bleeding risk exceeds benefit). For adults 40-59 with ≥10% 10-year cardiovascular risk, it’s a shared decision-making discussion. This represents a significant change from older guidance that more broadly recommended daily aspirin.

The Common NSAIDs Compared

The Gastrointestinal Risk

GI toxicity is the most common serious side effect of NSAIDs. The mechanism: inhibition of COX-1-derived prostaglandins in the gastric mucosa reduces the protective mucus layer and bicarbonate secretion, exposing the gastric epithelium to acid injury.

The GI consequences range from:

• Dyspepsia (stomach discomfort, heartburn, nausea) – very common, affecting 10-20% of NSAID users
• Gastric erosions – common on endoscopy, often asymptomatic
• Peptic ulcer disease – significant risk with regular NSAID use
• Gastrointestinal bleeding – the most serious complication; can be life-threatening

The GI risk is not trivial: An estimated 15-35% of peptic ulcer complications in the US are attributable to NSAID use. The absolute risk of a serious GI event is approximately 1-4% per year with regular NSAID use – which becomes substantial in populations taking them chronically.

Critical point: GI side effects from NSAIDs can occur without warning symptoms. Ulcers and GI bleeds caused by NSAIDs are often painless because the same prostaglandins that were suppressing mucosal pain are inhibited by the drug. “I don’t have stomach pain so my stomach must be fine” is not reliable with regular NSAID use.

Risk factors for GI complications:

• Age above 60 (risk increases substantially)
• Prior history of peptic ulcer or GI bleed
• Concurrent use of anticoagulants (warfarin, DOACs), corticosteroids, or other NSAIDs
• High doses or long duration
• H. pylori infection (synergistic risk)

Protective strategies:

• Proton pump inhibitors (PPIs) – omeprazole, pantoprazole, esomeprazole – taken alongside NSAIDs significantly reduce the risk of NSAID-induced ulcers and complications. Recommended for anyone at elevated GI risk taking NSAIDs regularly.
• COX-2 selective agents (celecoxib) – lower GI risk, but cardiovascular concerns limit them in high cardiovascular risk patients
• Topical NSAIDs (diclofenac gel) – for localized musculoskeletal pain, provide local anti-inflammatory effect with minimal systemic absorption and minimal GI risk

The Cardiovascular Risk

NSAIDs increase cardiovascular risk through effects on blood pressure, fluid retention, and the prostacyclin/thromboxane balance. This is a class effect – present to varying degrees with all non-aspirin NSAIDs.

Mechanisms:

• Fluid and sodium retention (reduced renal prostaglandins → reduced sodium excretion → higher blood pressure)
• Increased blood pressure: NSAIDs raise systolic BP by approximately 3-5 mmHg on average – clinically meaningful in patients with existing hypertension
• Shift toward prothrombotic state (particularly with COX-2 inhibitors, as discussed above)
• Increased heart failure risk from fluid retention

Cardiovascular risk varies by drug:

• Naproxen appears to have the lowest cardiovascular risk among traditional NSAIDs (consistent with the FDA’s cardiovascular labeling)
• Diclofenac and selective COX-2 inhibitors have higher cardiovascular risk
• Ibuprofen has intermediate risk
• All NSAIDs increase cardiovascular risk to some degree vs. no treatment in people with cardiovascular disease

Important interactions:

• NSAIDs blunt the antihypertensive effects of most blood pressure medications – particularly ACE inhibitors and ARBs
• NSAIDs reduce the antiplatelet effect of aspirin (naproxen and ibuprofen compete for the same binding site; if taken before aspirin, they can block aspirin’s irreversible platelet inhibition). For patients on cardioprotective aspirin: take aspirin first, then ibuprofen/naproxen 2+ hours later

Kidney Effects

Prostaglandins play an important role in maintaining renal blood flow – particularly when systemic blood flow is reduced (dehydration, heart failure, cirrhosis). NSAIDs reduce renal prostaglandins, which can cause:

• Acute kidney injury – particularly in people who are volume-depleted (dehydration, diuretics, diarrhea), have CKD, have heart failure, or are elderly
• Hypertension worsening
• Fluid retention/edema
• Hyperkalemia (reduced aldosterone effects from reduced prostaglandins)

The practical warning: NSAIDs should be used with extreme caution or avoided in people with existing kidney disease, heart failure, liver cirrhosis, or who are significantly dehydrated. This includes the “avoid NSAIDs when sick and dehydrated” rule – gastroenteritis combined with ibuprofen for fever is a common cause of acute kidney injury in otherwise healthy people.

NSAIDs in Specific Populations

Pregnancy: NSAIDs are contraindicated from 20 weeks gestation onward (risk of premature closure of the fetal ductus arteriosus and fetal renal toxicity). Use in the first trimester may increase miscarriage risk. Acetaminophen (Tylenol) is the preferred analgesic in pregnancy.

Older adults: The Beers Criteria (a geriatric prescribing guidance list) explicitly recommends against routine NSAID use in adults 65+ given significantly higher GI, cardiovascular, and kidney risks. When needed, lowest effective dose, shortest duration, and concurrent PPI are recommended.

Children: Ibuprofen is appropriate for pain and fever in children over 6 months. Aspirin is generally avoided in children with viral illnesses due to risk of Reye’s syndrome (a rare but serious neurological complication).

Asthma: NSAID-exacerbated respiratory disease (previously called aspirin-sensitive asthma) affects approximately 10-20% of asthmatic adults – NSAIDs trigger bronchospasm in this population. Acetaminophen is generally safer, though can also cause mild reactions in a subset.

When Acetaminophen Is the Better Choice

Acetaminophen (Tylenol) provides analgesia and antipyretic effects through different mechanisms (not COX inhibition) – without the GI, cardiovascular, or kidney risks of NSAIDs. It’s the preferred alternative when:

• GI disease or GI risk is present
• Cardiovascular disease or risk is elevated
• Kidney disease is present
• Pregnancy (from 2nd trimester)
• Older adults with multiple comorbidities

The key acetaminophen risk is hepatotoxicity – overdose (intentional or accidental) is the leading cause of acute liver failure in the US. The maximum dose is 3-4g/day in healthy adults, 2g/day in people who drink regularly. Many OTC combination products (cold medicine, sleep aids) contain acetaminophen – easy to accidentally exceed safe limits.

Frequently Asked Questions

Can I take ibuprofen every day for arthritis? Daily NSAID use for chronic conditions carries real cumulative GI, cardiovascular, and kidney risk. If daily NSAID use is needed for chronic pain or arthritis, this warrants medical assessment of the risk-benefit balance, consideration of a PPI for GI protection, monitoring of blood pressure and kidney function, and discussion of alternatives (acetaminophen, topical NSAIDs, physical therapy, disease-modifying treatments for inflammatory arthritis).

Is ibuprofen or naproxen better for inflammation? Both are effective anti-inflammatory agents. Naproxen has a longer duration (8-12 hours vs 4-6 for ibuprofen), which may suit chronic inflammation better. Naproxen may have a slightly better cardiovascular risk profile than ibuprofen. Ibuprofen has slightly more GI risk data. For most people, the practical difference is modest and individual response matters.

Can I take NSAIDs with blood thinners? This combination significantly increases bleeding risk – particularly GI bleeding. NSAIDs plus anticoagulants (warfarin, rivaroxaban, apixaban, dabigatran) or antiplatelets (clopidogrel, aspirin) should be used only when clearly necessary, with gastroprotection, and under medical supervision. This is a clinically important drug interaction.

Why can’t I take ibuprofen when I have a kidney infection? Kidney infections (pyelonephritis) and the accompanying fever and dehydration reduce renal blood flow. NSAIDs further reduce renal prostaglandins that maintain blood flow to the kidney under these stressed conditions – compounding the kidney strain. Acetaminophen is a safer choice for fever/pain management during kidney infections.

Does taking NSAIDs with food help with stomach problems? Taking NSAIDs with food can reduce dyspepsia (stomach discomfort) by reducing direct gastric mucosal contact. However, it does not protect against the systemic suppression of COX-1-mediated gastric mucosal protection – which happens regardless of whether NSAIDs are taken with food. Food reduces the symptom of upset stomach but not the underlying risk of ulcers or GI bleeding.

Disclaimer

This article is for educational purposes only and does not constitute medical advice. NSAID use in the context of cardiovascular disease, kidney disease, GI history, pregnancy, or other medical conditions should be discussed with a qualified healthcare provider. Do not change or stop prescription medications without medical guidance.

References

1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biology. 1971;231(25):232-235. https://doi.org/10.1038/newbio231232a0
2. Scheiman JM. NSAIDs, gastrointestinal injury, and cytoprotection. Gastroenterology Clinics of North America. 1996;25(2):279-298. https://doi.org/10.1016/S0889-8553(05)70371-3
3. Gunter BR, Butler KA, Wallace RL, Smith SM, Harirforoosh S. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis. Journal of Clinical Pharmacy and Therapeutics. 2017;42(1):27-38. https://doi.org/10.1111/jcpt.12484
4. US Food and Drug Administration. FDA drug safety communication: NSAIDs and cardiovascular risk. https://www.fda.gov/drugs/drug-safety-and-availability
5. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Journal of the American College of Cardiology. 2019;74(10):e177-e232. https://doi.org/10.1016/j.jacc.2019.03.010
6. Lanza FL, Chan FK, Quigley EM; Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. American Journal of Gastroenterology. 2009;104(3):728-738. https://doi.org/10.1038/ajg.2009.115
7. American Geriatrics Society. 2023 American Geriatrics Society Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. 2023;71(7):2052-2081. https://doi.org/10.1111/jgs.18372
8. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). NSAIDs. https://www.niams.nih.gov
9. Sostres C, Gargallo CJ, Arroyo MT, Lanas A. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Practice & Research Clinical Gastroenterology. 2010;24(2):121-132. https://doi.org/10.1016/j.bpg.2009.11.005
10. MedlinePlus. Ibuprofen. https://medlineplus.gov/druginfo/meds/a682159.html